Previous Page  5 / 8 Next Page
Information
Show Menu
Previous Page 5 / 8 Next Page
Page Background

Page 13

Notes:

allied

academies

Asian Journal of Biomedical and Pharmaceutical Sciences | Volume 8

May 14-15, 2018 | Montreal, Canada

Global Summit on

Biopharma & Biotherapeutics

C

eramides are composed of a sphingoid base attached to

a fatty acid via an amide bond. These lipids serve both a

structural role in membranes and an intracellular signaling

role within a cell. Ceramide is a natural molecule that targets

discrete kinases and signaling pathways linked to proliferation

and/or survival. Due to its potent regulation of cell growth,

differentiation, and death, ceramide has been identified as

a putative therapeutic agent in cancer and cardiovascular

disease. The use of ceramide to inhibit Akt signaling is a novel

approach under preclinical evaluation. Ceramide targets the

PI3K/Akt pathway through dephosphorylation of Akt, leading to

increased cytotoxicity and cell apoptosis when in combination

with another chemotherapeutics, can enhance cell death.

An obstacle that has limited clinical use of ceramide is its

hydrophobicity, which can be overcome by packaging it into a

nanoliposomal formulation for systemic delivery. Hydrophilic

drugs can be entrapped in the aqueous compartment, while

the lipid bilayer can be utilized to incorporate hydrophobic

drugs. Associating a drug with liposome markedly changes

its pharmacokinetic properties and lowers systemic toxicity;

furthermore, the drug is prevented form early degradation

and/or inactivation in circulation. This presentation discusses

the role of ceramides in the formulation of liposomes for the

delivery of model anti-cancer drugs such as doxorubicin and

daunorubicin. The synergistic function of ceramide based

liposomal formulations in melanoma, breast and prostate

cancers will be discussed

Speaker Biography

Jay Babu Ramapuram has completed his PhD from Indian Institute of Technology,

Varanasi, India. He is the Professor in the Dept. of Drug Discovery and Development

at Auburn University, USA. He has over 80 publications that have been cited over 1300

times, and his publication H-index is 21 and has been serving as an Editorial Board

Member of reputed Journals in his research area.

e:

rjbabu68@gmail.com

Jay Babu Ramapuram

Auburn University, USA

Ceramides based liposomes for melanoma treatment